Prokineticin Receptor 2 anticorps (C-Term)

N° du produit ABIN375371

L’anticorps Lapin Polyclonal anti-Prokineticin Receptor 2 a été validé pour ELISA, WB et IF. Il convient pour détecter Prokineticin Receptor 2 dans des échantillons de Souris. Il y a 1 publication disponible.

Aperçu rapide pour Prokineticin Receptor 2 anticorps (C-Term) (ABIN375371)

Antigène: Prokineticin Receptor 2 (PROKR2)

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Prokineticin Receptor 2 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunofluorescence (IF)

Détail du produit anti-Prokineticin Receptor 2 anticorps

Épitope: C-Term

Specificité: Reacts with mouse PK-R2

Réactivité croisée: Souris

Réactivité croisée (Details): Predicted to cross reacts with PK-R2 and PK-R1 from mouse, rat, human and bovin.

Purification: Antiserum

Immunogène: Synthetic peptide derived from Cter domain of mouse PK-R2

Isotype: IgG

Information d'application

Indications d'application:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IF(1:50 - 1:500) WB(1:500 - 1:2000)

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Must be reconstituted in distilled water.

Stock: 4 °C/-20 °C

Stockage commentaire: Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Date de péremption: 24 months

Références pour anticorps anti-Prokineticin Receptor 2 (ABIN375371)

Ito, Noda, Yoshida, Otani, Yoshiga, Oto, Saito, Kurosaka: "Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis." dans: BMC musculoskeletal disorders, Vol. 17, pp. 387, (2016) (PubMed).

Détails sur Prokineticin Receptor 2

Antigène: Prokineticin Receptor 2 (PROKR2)

Autre désignation: Prokineticin Receptor 2 (PK-R2)

UniProt: Q8K458

Pathways: Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma